Cytochrome P-450-mediated differential oxidative modification of proteins: Albumin, apolipoprotein E, and CYP2E1 as targets

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 23-24, 2004, Pages 2061-2071

  Dal, Woong Choi ^a,c   Leininger Muller, Brigitte ^a   Wellman, Maria ^b   Young, Hwan Kim ^c   Siest, Gerard ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; CYTOCHROME P450; CYTOCHROME P450 2E1; CYTOCHROME P450 INHIBITOR;

CONFERENCE PAPER; MICROSOME; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN TARGETING; RADICAL REACTION; XENOBIOTIC METABOLISM;

ALBUMINS; ANIMALS; APOLIPOPROTEINS E; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; ISOENZYMES; MALE; MICROSOMES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; XENOBIOTICS;

EID: 8444248657     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390490514895     Document Type: Conference Paper

References (30)

1. Barbier, A., Visvikis, A., Mathieu, F., Diez, L., Havekes, L. M., and Siest, G. 1997. Characterization of three human apolipoprotein E isoforms (E2, E3 and E4) expressed in Escherichia coli. Eur. J. Clin. Chem. Clin. Biochem. 35:581-589.
2. Cairns S. R., and Peters, T. J. 1984. Isolation of micro- and macro-droplet fractions from needle biopsy specimens of human liver and determination of the subcellular distribution of the accumulating liver lipids in alcoholic fatty liver. Clin. Sci. (Lond.) 67:337-345.
3. Davignon, J., Cohn, J. S., Mabile, L., and Bernier, L. 1999. Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin. Chim. Acta. 286:115-143.
4. Farin, F. M., and Omiecinski, C. J. 1993. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. Environ. Health 40:317-335.
5. Ferris, G. M., and Clark, J. B. 1972. The control of nucleic acid and nicotinamide nucleotide synthesis in regenerating rat liver. Biochem. J. 128:869-877.
6. Friguet, B., and Szweda, L. I. 1997. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405:21-25.
7. Gonzalez F. J., and Gelboin, H. V. 1993. Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Health 40:289-308.
8. Grune, T., Reinheckel, T., Joshi, M., and Davies, K. J. 1995. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270:2344-2351.
9. Hamilton, R. L., Wong, J. S., Guo, L. S., Krisans, S., and Havel, R. J. 1990. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid. Res. 31:1589-1603.
10. Hutson, J. L., and Wickramasinghe, S. N. 1999. Expression of CYP2E1 by human monocyte-derived macrophages. J. Pathol. 188:197-200.
11. Jessup, W., Mander, E. L., and Dean, R. T. 1992. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim. Biophys. Acta 1126:167-177.
12. Johansson, I., Ekstrom, G., Scholte, B., Puzycki, D., Jornvall, H., and Ingelman-Sundberg, M. 1988. Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: Regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry 27:1925-1934.
13. Jolivalt, C., Leininger-Muller, B., Drozdz, R., Naskalski, J. W., and Siest, G. 1996. Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci. Lett. 210:61-64.
14. Jolivalt, C., Leininger-Muller, B., Bertrand, P., Herber, R., Christen, Y., and Siest, G. 2000. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radical. Biol. Med. 28:129-140.
15. Kuipers, F., van Ree, J. M., Hofker, M. H., Wolters, H., In't Veld, G., Havinga, R., Vonk, R. J., Princen, H. M., and Havekes, L. M. 1996. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24:241-247.
16. Kuipers, F., Jong, M. C., Lin, Y., Eck, M., Havinga, R., Bloks, V., Verkade, H. J., Hofker, M. H., Moshage, H., Berkel, T. J., Vonk, R. J., and Havekes, L. M. 1997. Impaired secretion of very low density lipoprotein- triglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 100:2915-2922.
17. Lombardi, P., Mulder, M., van der Boom, H., Frants, R. R., and Havekes, L. M. 1993. Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. J. Biol. Chem. 268:26113-26119.
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275.
19. Mahley, R. W., and Huang, Y. 1999. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10:207-217.
20. Mazzone, T. 1996. Apolipoprotein E secretion by macrophages: Its potential physiological functions. Curr. Opin. Lipidol. 7:303-307.
21. McGuire, J. J., Anderson, D. J., McDonald, B. J., Narayanasami, R., and Bennett, B. M. 1998. Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate. Biochem. Pharmacol. 56:881-893.
22. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166.
23. Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., and Mahley, R. W. 1987. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917:148-161.
24. Puntarulo, S., and Cederbaum, A. I. 1998. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radical. Biol. Med. 24:1324-1330.
25. Roberts, B. J. 1997. Evidence of proteasome-mediated cytochrome P-450 degradation. J. Biol. Chem. 272:9771-9778.
26. Schwiegelshohn, B., Presley, J. F., Gorecki, M., Vogel, T., Carpentier, Y. A., Maxfield, F. R., and Deckelbaum, R. J. 1995. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J. Biol. Chem. 270:1761-1769.
27. Serron, S. C., Dwivedi, N., and Backes, W. L. 2000. Ethylbenzene induces microsomal oxygen free radical generation: Antibody-directed characterization of the responsible cytochrome P450 enzymes. Toxicol. Appl. Pharmacol. 164:305-311.
28. Ueng, T. H., Hwang, W. P., Chen, R. M., Wang, H. W., Kuo, M. L., Park, S. S., and Guengerich, F. P. 1998. Effects of motorcycle exhaust on cytochrome P-450-dependent monooxygenases and glutathione S-transferase in rat tissues. J. Toxicol. Environ. Health A 54:509-527.
29. Wu, D., and Cederbaum, A. I. 1992. Presence of functionally active cytochrome P-450IIE1 in the plasma membrane of rat hepatocytes. Hepatology 15:515-524.
30. Yang, Y., Fruh, K., Ahn, K., and Peterson, P. A. 1995. In vivo assembly of the proteasomal complexes, implications for antigen processing. J. Biol. Chem. 270:27687-27694.